SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-028359
Filing Date
2022-03-01
Accepted
2022-03-01 08:43:00
Documents
15
Period of Report
2022-03-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm227895d1_8k.htm   iXBRL 8-K 26507
2 EXHIBIT 99.1 tm227895d1_ex99-1.htm EX-99.1 122219
7 GRAPHIC tm227895d1_ex99-1img001.jpg GRAPHIC 3100
  Complete submission text file 0001104659-22-028359.txt   385630

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA albo-20220301.xsd EX-101.SCH 3286
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE albo-20220301_def.xml EX-101.DEF 26456
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE albo-20220301_lab.xml EX-101.LAB 36200
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE albo-20220301_pre.xml EX-101.PRE 25114
9 EXTRACTED XBRL INSTANCE DOCUMENT tm227895d1_8k_htm.xml XML 4681
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33451 | Film No.: 22694227
SIC: 2834 Pharmaceutical Preparations